Sampang, Yoshra H.
HRN: 11-85-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2022
CEFUROXIME 1.5GM (VIAL)
07/18/2022
07/25/2022
IVT
1.5g
Q8
S/P Salpingo-oophorectomy
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes